Anti-SARS-CoV-2 antibodies in healthy donor plasma pools and IVIG products-an update.

作者信息

Romero Carolina, Díez José-María, Gajardo Rodrigo

机构信息

Immunotherapies Unit, Global Research & Development, Bioscience R&D Scientific Innovation Office, Grifols, Barcelona 08150, Spain.

出版信息

Lancet Infect Dis. 2022 Jan;22(1):19. doi: 10.1016/S1473-3099(21)00755-6.

DOI:10.1016/S1473-3099(21)00755-6

PMID:34953544

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8694747/

Abstract

摘要

相似文献

[1]

Anti-SARS-CoV-2 antibodies in healthy donor plasma pools and IVIG products-an update.

Lancet Infect Dis. 2022-1

[2]

Anti-SARS-CoV-2 antibodies in healthy donor plasma pools and IVIG products.

Lancet Infect Dis. 2021-6

[3]

Anti-SARS-CoV-2 Antibodies Within IVIg Preparations: Cross-Reactivities With Seasonal Coronaviruses, Natural Autoimmunity, and Therapeutic Implications.

Front Immunol. 2021

[4]

Antibody response after COVID-19 vaccination in intravenous immunoglobulin-treated immune neuropathies.

Eur J Neurol. 2022-11

[5]

Highly Potent SARS-CoV-2 Neutralization by Intravenous Immunoglobulins manufactured from Post-COVID-19 and COVID-19-Vaccinated Plasma Donations.

J Infect Dis. 2021-11-22

[6]

The presumed protective effect of IVIG against SARS-CoV-2 in inflammatory myopathy patients remains questionable.

Rheumatol Int. 2024-2

[7]

Pre-COVID-19 Immunity to Common Cold Human Coronaviruses Induces a Recall-Type IgG Response to SARS-CoV-2 Antigens Without Cross-Neutralisation.

Front Immunol. 2022

[8]

Modelling the concentration of anti-SARS-CoV-2 immunoglobulin G in intravenous immunoglobulin product batches.

PLoS One. 2021

[9]

IgG response to spike protein of SARS-CoV-2 in healthy individuals and potential of intravenous IgG as treatment for COVID-19.

Virol J. 2022-11-13

[10]

Seroprevalence of SARS-CoV-2 among potential convalescent plasma donors and analysis of their deferral pattern: Experience from tertiary care hospital in western India.

Transfus Clin Biol. 2022-2

引用本文的文献

[1]

Contribution of immunoglobulin products in influencing seasonal influenza infection and severity in antibody immune deficiency patients receiving immunoglobulin replacement therapy.

Front Immunol. 2024

[2]

Protecting children and adults with primary antibody deficiencies against common and emergent pathogens and non-infectious complications.

Clin Exp Immunol. 2024-10-16

[3]

An Overview of the Strategies to Boost SARS-CoV-2-Specific Immunity in People with Inborn Errors of Immunity.

Vaccines (Basel). 2024-6-18

[4]

Intravenous immunoglobulins for the treatment of prolonged COVID-19 in immunocompromised patients: a brief report.

Front Immunol. 2024

[5]

Generalized myasthenia gravis with acetylcholine receptor antibodies: A guidance for treatment.

Eur J Neurol. 2024-5

[6]

Intravenous immunoglobulin for treatment of hospitalized COVID-19 patients: an evidence mapping and meta-analysis.

Inflammopharmacology. 2024-2

[7]

Teclistamab impairs humoral immunity in patients with heavily pretreated myeloma: importance of immunoglobulin supplementation.

Blood Adv. 2024-1-9

[8]

IVIg Use Associated with Ten-Fold Reduction of Serious Infections in Multiple Myeloma Patients Treated with Anti-BCMA Bispecific Antibodies.

Blood Cancer Discov. 2023-11-1

[9]

Assessment of antibody levels to SARS-CoV-2 in patients with idiopathic inflammatory myopathies receiving treatment with intravenous immunoglobulin.

Rheumatol Int. 2023-9

[10]

T cell immunity following COVID-19 vaccination in adult patients with primary antibody deficiency - a 22-month follow-up.

Front Immunol. 2023

本文引用的文献

[1]

Efficacy of IVIG (intravenous immunoglobulin) for corona virus disease 2019 (COVID-19): A meta-analysis.

Int Immunopharmacol. 2021-7

[2]

Anti-SARS-CoV-2 antibodies in healthy donor plasma pools and IVIG products.

Lancet Infect Dis. 2021-6

[3]

Currently available intravenous immunoglobulin contains antibodies reacting against severe acute respiratory syndrome coronavirus 2 antigens.

Immunotherapy. 2020-5-12

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

新学期，新优惠

Anti-SARS-CoV-2 antibodies in healthy donor plasma pools and IVIG products-an update.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

推荐工具

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献